Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$30.95 - $39.68 $161,435 - $206,970
-5,216 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$32.88 - $44.57 $171,502 - $232,477
5,216 New
5,216 $213,000
Q1 2021

May 11, 2021

SELL
$30.92 - $44.4 $161,278 - $231,590
-5,216 Closed
0 $0
Q4 2020

Feb 04, 2021

BUY
$33.66 - $40.76 $175,570 - $212,604
5,216 New
5,216 $212,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $15.2B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Cadence Bank Portfolio

Follow Cadence Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cadence Bank, based on Form 13F filings with the SEC.

News

Stay updated on Cadence Bank with notifications on news.